Expression of macrophage migration inhibitory factor in the human prostate

Diagnostic Molecular Pathology

Volumn 7, Issue 1, 1998, Pages 44-50

  Meyer Siegler, Katherine ^a,b   Fattor, Ron A ^a,b   Hudson, Perry B ^a,b  

^a Bay Pines VA Medical Center   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Enzyme linked immunosorbent assay; Immunohistochemistry; Macrophage migration inhibitory factor; Northern blot; Prostate neoplasms; Prostate tissue

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; CARCINOMA CELL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; PREPUBERTY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PUBERTY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELLS, CULTURED; CHILD; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0031803372     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199802000-00008     Document Type: Article

References (29)

1. Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 1992;52:5991-6.
2. Bailey N. Statistical methods in biology. Cambridge: Cambridge University Press, 1995.
3. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, R B. Purification, bioactivity and secondary structure analysis of rat and human macrophage migration inhibitory factor (MIF). Biochemistry 1994;33:14144-55.
4. Bloom B, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966;153:80-2.
5. Bucala R. MIF, a previously unrecognized pituitary hormone and macrophage cytokine, is a pivotal mediator in endotoxic shock. Circulatory Shock 1994;44:35-9.
6. Calandra T, Bernhagen J, Metz C, et al. MIF as a glucocorticoid induced modulator of cytokine production. Nature 1995;377:68-71.
7. Chung LWK. Implications of stromal-epithelial interaction in human prostate cancer growth, progression and differentiation. Cancer Biol 1993;4:183-92.
8. Chung LWK, Li W, Gleave ME, et al. Human prostate cancer models: roles of growth factors and extracellular matrices. J Cell Biochem 1992;16H:99-105.
9. Diamandis EP. New diagnostic applications and physiological functions of prostate specific antigen. Scand J Clin Lab Invest 1995;55:105-12.
10. Effert PJ, Neubauer A, Walther PJ, Liu ET. Alterations of the p53 gene are associated with the progression of a human prostate carcinoma. J Urol 1992;147:789-93.
11. Galat A, Riviere S, Bouet F. Purification of macrophage migration inhibitory factor (MIF) from bovine brain cytosol. FEBS Lett 1993; 319:233-6.
12. Hirokawa J, Sakaue S, Tagami S, et al. Identification of macrophage migration inhibitory factor in adipose tissue and its induction by TNF-alpha. Biochem Biophys Res Commun 1997;235: 94-8.
13. Isaacs WB, Bova S, Morton RA, Bussemakers MJG, Brooks JD, Ewing CM. Molecular genetics and chromosomal alterations in prostate cancer. Cancer 1995;75:2004-12.
14. Lan HY, Bacher M, Yang N, et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 1997;185:1455-65.
15. Lombardo ME, Meyer-Siegler K, Hakky S, Hudson PB. The isolation and characterization of predominate prostatic proteins. Prostate 1996;29:381-5.
16. McDonald TJ, Troncoso P, Brisbay SM, et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992; 52:6940-4.
17. Meinhardt A, Bacher M, McFarlane JR, et al. Macrophage migration inhibitory factor production by Leydig cells: evidence for a role in the regulation of testicular function. Endocrinology 1996; 137:5090-5.
18. Melefors O, Hentze M. Translational regulation by mRNA/protein interactions in eukaryotic cells: ferritin and beyond. Bioessays 1993;15:85-90.
19. Meyer-Siegler K, Hudson PB. Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases. Urology 1996;48:448-52.
20. Navone NM, Troncoso P, Pisters LL, et al. p53 accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 1993;85:1657-69.
21. Paralkar V, Wistow G. Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 1994;19:48-51.
22. Rinker-Schaeffer CW, Partin AW, Isaacs WB, Coffey DS, Isaacs JT. Molecular and cellular changes associated with the acquisition of metastatic ability by prostate cancer cells. Prostate 1994;25: 249-65.
23. Sadasivan R, Morgan R, Jennings S, et al. Overexpression of her-2/neu may be an indicator of poor prognosis in prostate cancer. J Urol 1993;150:126-31.
24. Shimizu T, Ohkawara A, Nishihira J, Sakamoto W. Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS Lett 1996;381: 199-202.
25. Smith M, Biggar S, Hussain M. Prostate-specific antigen messenger RNA is expressed in non-prostate cells. Cancer Res 1995;55: 2640-44.
26. Suzuki H, Nishihira J, Koyama Y, Kanagawa H. The role of macrophage migration inhibitory factor in pregnancy and the development of murine embryos. Biochem Mol Biol Int 1996;38:409-16.
27. Wada S, Fujimoto S, Mizue Y, Nishihira J. Macrophage migration inhibitory factor in the human ovary: presence in the follicular fluids and production by granulosa cells. Biochem Mol Biol Int 1997;41:805-14.
28. Waeber G, Calandra T, Roduit R, et al. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1997; 94:4782-7.
29. Wistow GJ, Shaughnessy MP, Lee DC, Hodin J, Zelenka PS. A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc Natl Acad Sci USA 1993;90: 1271-5.